The 12 analysts offering 1 year price forecasts for GLENMARK have a max estimate of — and a min estimate of —.
Analyst rating
Based on 12 analysts giving stock ratings to GLENMARK in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GLENMARK EPS for the last quarter is −12.50 INR despite the estimation of 12.08 INR. In the next quarter EPS is expected to reach 5.50 INR. Track more of GLENMARK PHARM financials and stay on top of what is up with the company.
In the next quarter GLENMARK PHARM revenue is expected to reach 32.80 B INR. Check out GLENMARK PHARM revenue and earnings and make informed decisions.
According to analysts, GLENMARK price target is 984.33 INR with a max estimate of 1266.00 INR and a min estimate of 570.00 INR. Check if this forecast comes true in a year, meanwhile keep track of the current situation with GLENMARK news and stock market news.
We've gathered opinions of 12 analysts rating GLENMARK stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.